MB "Farmonika" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 43,641 |
| - |
| 3,906 |
| 3,711 |
| - |
| 100.00 |
| 8.50 |
| 5,811 |
| 195 |
| 0 |
| 6,006 |
| 0.13 |
| 0.03 |
| - |
| - |
| 8.95 |
| 3,906 |
| 2024 |
|---|
| 55,782 |
| - |
| 103 |
| 97 |
| - |
| 100.00 |
| 0.17 |
| 1,408 |
| 2,979 |
| 0 |
| 4,387 |
| 0.03 |
| 2.12 |
| - |
| - |
| 0.20 |
| 113 |
| 2025 |
|---|
| 75,011 |
| - |
| 4,881 |
| 4,588 |
| - |
| 100.00 |
| 6.12 |
| 5,996 |
| 495 |
| 0 |
| 6,491 |
| 0.08 |
| 0.08 |
| - |
| - |
| 6.51 |
| 4,881 |
| 2025 |
|---|
| 75,011 |
| - |
| 4,881 |
| 4,588 |
| - |
| 100.00 |
| 6.12 |
| 5,996 |
| 495 |
| 0 |
| 6,491 |
| 0.08 |
| 0.08 |
| - |
| - |
| 6.51 |
| 4,881 |
Turnover (€)
2025
Turnover (€)
75,011 €34 % *
Sales per employee (€)
-Profit before tax (€)
4,881 €4,639 % *
Net Profit (€)
4,588 €4,630 % *
Profit per employee (€)
-Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
6.12 %3,500.00 % *
Equity (€)
5,996 €326 % *
Amounts Payable And Liabilities (€)
495 €-83 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
6,491 €48 % *
Working capital requirement
0.08 166.67 % *
Debt-to-equity ratio
0.08 -96.23 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
6.51 %3,155.00 % *
EBIT (€)
4,881 €4,219 % *
